Abstract

A pleural effusion is the accumulation of fluid in the pleural space. It is a relatively common finding in clinical practice. The diagnostic approach to the patient presenting with a pleural effusion is aimed at defining the effusion as a transudate or an exudate. This review summarises the initial assessment and investigation of pleural effusions diagnosed during the acute medical take, and who should be referred for specialist advice. In addition, recent developments, including the measurement of NT-proBNP levels and diagnostic markers for mesothelioma, are presented.
[download-attachments container="div" style="list" dipslay_icon="1" display_count="1" display__size="0"]

References

1. Marel M, Zrustova M, Stasny B, et al. The incidence of pleural effusion in a well-defined region - epidemiologic-study in Central Bohemia. Chest 1993; 104(5): 1486–1489.
2. Noppen M, de Waele M, Li R, et al. Volume and cellular content of normal pleural fluid in humans examined by pleural lavage. American Journal of Respiratory and Critical Care Medicine 2000; 162(3): 1023–1026.
3. Maskell NA, Butland RJA, Grp BPD. BTS guidelines for the investigation of a unilateral pleural effusion in adults. Thorax 2003; 58: II8–II17.
4. Light RW. Pleural effusion due to pulmonary emboli. Curr Opin Pulm Med 2001; 7(4): 198–201.
5. Light RW. Pleural effusion. New England Journal of Medicine 2002; 346(25): 1971–1977.
6. Foucher P, Camus P, et al. Pneumotox website: http://www.pneumotox. com/. Accessed on 27th August 2007.
7. Blackmore CC, Black WC, Dallas RV, et al. Pleural fluid volume estimation: A chest radiograph prediction rule. Academic Radiology 1996; 3(2): 103–109.
8. Porcel JM, Light RW. Diagnostic approach to pleural effusion in adults. American Family Physician 2006; 73(7): 1211–1220.
9. Porcel JM, Vives M. Etiology and pleural fluid characteristics of large and massive effusions. Chest 2003; 124(3): 978–983.
10. Eibenberger KL, Dock WI, Ammann ME, et al. Quantification of pleural effusions-sonography versus radiography. Radiology 1994; 191(3): 681–684.
11. Leung AN, Muller NL, Miller RR. CT in differential-diagnosis of diffuse pleural disease. American Journal of Roentgenology 1990; 154(3): 487–492.
12. Shinto RA, Light RW. Effects of diuresis on the characteristics of pleural fluid in patients with congestive heart-failure. American Journal of Medicine 1990; 88(3): 230–234.
13. Ferrer A, Osset J, Alegre J, et al. Prospective clinical and microbiological study of pleural effusions. European Journal of Clinical Microbiology & Infectious Diseases 1999; 18(4): 237–241.
14. Light RW, Erozan YS, Ball WC. Cells in pleural fluid - their value in differential diagnosis. Archives of Internal Medicine 1973; 132(6): 854–860.
15. Light RW, Luchsing P, Macgrego M, et al. Pleural effusions - diagnostic separation of transudates and exudates. Annals of Internal Medicine 1972; 77(4): 507-&.
16. Burgess LJ, Maritz FJ, Taljaard JJF. Comparative-analysis of the biochemical parameters used to distinguish between pleural transudates and exudates. Chest 1995; 107(6): 1604–1609.
17. Sahn SA, Good JT. Pleural fluid pH in malignant effusions - diagnostic, prognostic, and therapeutic implications. Annals of Internal Medicine 1988; 108(3): 345–349.
18. Davies CWH, Gleeson FV, Davies RJO. BTS Pleural Diseases Grp. BTS guidelines for the management of pleural infection. Thorax 2003; 58: II18–II28.
19. Antunes G, Neville E, Duffy J, et al. Grp BTSPD. BTS guidelines for the management of malignant pleural effusions. Thorax 2003; 58: II29–II38.
20. Berger HW, Mejia E. Tuberculous pleurisy. Chest 1973; 63(1): 88–92.
21. Greco S, Girardi E, Masciangelo R, et al. Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculous pleurisy: a meta-analysis. International Journal of Tuberculosis and Lung Disease 2003; 7(8): 777–786.
22. Villegas MV, Labrada LA, Saravia NG. Evaluation of polymerase chain reaction, adenosine deaminase, and interferon-gamma in pleural fluid for the differential diagnosis of pleural tuberculosis. Chest 2000; 118(5): 1355–1364.
23. Lainchbury JG, Campbell E, Frampton CM, et al. Brain natriuretic peptide and N-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. Journal of the American College of Cardiology 2003; 42(4): 728–735.
24. Kolditz M, Halank M, Schmeisser CS, et al. High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions. European Respiratory Journal 2006; 28(1): 144–150.
25. Porcel JM, Vives M, Cao G, et al. Measurement of pro-brain natriuretic peptide in pleural fluid for the diagnosis of pleural effusions due to heart failure. American Journal Of Medicine 2004; 116(6): 417–420.
26. Robinson BWS, Musk AW, Lake RA. Malignant mesothelioma. Lancet 2005; 366(9483): 397–408.
27. Creaney J, Yeoman D, Naumoff LK, et al. Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma. Thorax 2007; 62(7): 569–576.
28. Porcel JM, Ruiz-Gonzalez A, Falguera M, et al. Contribution of a pleural antigen assay (Binax NOW) to the diagnosis of pneumococcal pneumonia. Chest 2007; 131(5): 1442–1447.
29. Hirsch A, Ruffie P, Nebut M, et al. Pleural effusion - laboratory tests in 300 cases. Thorax 1979; 34(1): 106–112.
30. Ferrer JS, Munoz XG, Orriols RM, et al. Evolution of idiopathic pleural effusion - A prospective, long-term follow-up study. Chest 1996;109(6): 1508–1513